| Date Filed | Type | Description |
| 05/22/2023 |
4
| NEIL GARRY ARTHUR (Director) has filed a Form 4 on Zura Bio Ltd|
Txns:
| Granted 7,652 options to buy
@ $5.31, valued at
$40.6k
|
|
| 05/17/2023 |
4
| NEIL GARRY ARTHUR (CEO and Chairman of the Board) has filed a Form 4 on Avalo Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.75, valued at
$275k
|
|
| 03/21/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/12/2022 |
4
| NEIL GARRY ARTHUR (CEO and Chairman of the Board) has filed a Form 4 on Avalo Therapeutics, Inc.|
Txns:
| Bought 2,083 shares
@ $4.42, valued at
$9.2k
|
|
| 10/07/2022 |
4
| NEIL GARRY ARTHUR (CEO and Chairman of the Board) has filed a Form 4 on Avalo Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $3.97, valued at
$297.8k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2022 |
4
| NEIL GARRY ARTHUR (CEO) has filed a Form 4 on Avalo Therapeutics, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $0.7, valued at
$700k
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| NEIL GARRY ARTHUR (Chief Scientific Officer) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 260,000 options to buy
@ $3.32, valued at
$863.2k
|
|
| 12/14/2020 |
4
| NEIL GARRY ARTHUR (Chief Scientific Officer) has filed a Form 4 on Cerecor Inc.|
Txns:
| Bought 3,599 shares
@ $2.278, valued at
$8.2k
|
|
| 06/16/2020 |
4
| NEIL GARRY ARTHUR (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 2,446 shares
@ $0
Granted 5,000 options to buy
@ $61.31, valued at
$306.6k
|
|
| 06/11/2020 |
4
| NEIL GARRY ARTHUR (Chief Scientific Officer) has filed a Form 4 on Cerecor Inc.|
Txns:
| Bought 1,799 shares
@ $2.278, valued at
$4.1k
|
|
| 02/05/2020 |
4
| NEIL GARRY ARTHUR (Chief Medical Officer) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 72,282 shares
@ $0
Granted 800,000 options to buy
@ $3.98, valued at
$3.2M
|
|
| 02/05/2020 |
3
| NEIL GARRY ARTHUR (Chief Medical Officer) has filed a Form 3 on Cerecor Inc. |
| 02/05/2020 |
4
| NEIL GARRY ARTHUR (Chief Scientific Officer) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Disposed/sold 2,164,150 shares
@ $0
Disposed/sold 900,000 options to buy
@ $4.22, valued at
$3.8M
Disposed/sold 13,532 options to buy
@ $6.45, valued at
$87.3k
Disposed/sold 200,000 options to buy
@ $7.01, valued at
$1.4M
Disposed/sold 200,000 options to buy
@ $4.83, valued at
$966k
Disposed/sold 200,000 options to buy
@ $4.91, valued at
$982k
Disposed/sold 100,000 options to buy
@ $1.32, valued at
$132k
Disposed/sold 13,334 options to buy
@ $2.84, valued at
$37.9k
Disposed/sold 300,000 options to buy
@ $1.51, valued at
$453k
Disposed/sold 261,000 options to buy
@ $1.55, valued at
$404.6k
|
|
| 12/09/2019 |
4
| NEIL GARRY ARTHUR (Chief Scientific Officer) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Bought 2,049,376 shares
@ $0.134, valued at
$274.6k
|
|
| 06/17/2019 |
4
| NEIL GARRY ARTHUR (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 2,654 shares
@ $0
Granted 5,000 options to buy
@ $56.5, valued at
$282.5k
|
|
| 01/03/2019 |
4
| NEIL GARRY ARTHUR (Director) has filed a Form 4 on GTX INC /DE/|
Txns:
| Granted 14,535 shares
@ $0.86, valued at
$12.5k
|
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2018 |
4
| NEIL GARRY ARTHUR (Director) has filed a Form 4 on GTX INC /DE/|
Txns:
| Granted 808 shares
@ $15.47, valued at
$12.5k
|
|
| 06/18/2018 |
4
| NEIL GARRY ARTHUR (Chief Scientific Officer) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 261,000 options to buy
@ $1.55, valued at
$404.6k
|
|
| 06/15/2018 |
4
| NEIL GARRY ARTHUR (Director) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 3,050 shares
@ $0
Granted 5,000 options to buy
@ $49.17, valued at
$245.9k
|
|
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2018 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/11/2018 |
4
| NEIL GARRY ARTHUR (Director) has filed a Form 4 on GTX INC /DE/|
Txns:
| Granted 7,500 options to buy
@ $17.2, valued at
$129k
|
|
| 04/03/2018 |
4
| NEIL GARRY ARTHUR (Director) has filed a Form 4 on GTX INC /DE/|
Txns:
| Granted 716 shares
@ $17.47, valued at
$12.5k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2017 |
4
| NEIL GARRY ARTHUR (Chief Scientific Officer) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Bought 75,000 shares
@ $1.26, valued at
$94.5k
Bought 13,344 warrants
@ $2.84, valued at
$37.9k
|
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|